Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response

Institutions FC
Department of Medical Oncology, DFCI, United States of America (USA) 0.27
Novartis Institutes for Biomedical Research (NIBR), Switzerland 0.20
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.20
Harvard Graduate School of Arts and Sciences (GSAS), United States of America (USA) 0.13
Department of Medicine (DOM), BWH, United States of America (USA) 0.12
National Centre for Biological Sciences (NCBS), TIFR, India 0.05
Nanobioengineering Group, IBEC BIST, Spain 0.03

Return